LicianPro

NVO stock

Novo Nordisk A S (NVO) short interest & short volume · 37.4M shares short

Novo Nordisk A S official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

NVO short interest rose 18.4% to 37.4M shares in the Oct 15, 2026 report (3.1 days to cover). Daily short volume averaged 41.5% of volume over the last 20 sessions, down from 44.2% the 20 sessions before, the 67th percentile of its own 20-day averages since Sep 23, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
37.4M
prior 31.6M
% of float
—
no float on file
Days to cover
3.1
avg vol 12.1M
Change vs prior report
+18.4%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 2)
45.7%
2.0M of 4.3M
20-day average
41.5%
prior 44.2%
Percentile vs own history
67th
233 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026

Short squeeze score (model)

Price since settlement: +2.5%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

NVO's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · NVO overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-021,982,1804,337,82245.7%
2026-10-302,758,5086,158,45644.8%
2026-10-291,666,1034,181,26939.9%
2026-10-281,204,6323,395,03935.5%
2026-10-271,723,0673,024,13657.0%
2026-10-261,124,7062,946,20638.2%
2026-10-231,292,9223,033,32042.6%
2026-10-221,177,3493,337,70035.3%
2026-10-211,050,2542,632,65139.9%
2026-10-201,400,6473,910,05735.8%

Healthcare peers with similar quant ratings

NVO is rated 4.24 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works

NVO on Lician stock screens

NVO is rated Buy (4.24 of 5) and passes 2 of 9 preset screens on the Nov 4, 2026 quant run. Build your own screen

NVO short interest FAQ

What is NVO's short interest?

Novo Nordisk A S (NVO) had 37.4M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report.

How many days to cover does NVO have?

3.1 days: 37.4M shares short divided by an average daily volume of 12.1M for the Oct 15, 2026 period.

Is NVO short interest rising or falling?

NVO short interest rose (+18.4%) from 31.6M to 37.4M shares in the Oct 15, 2026 report.

Is NVO a short squeeze candidate?

Lician's squeeze watch scores NVO 15 out of 100 (low) from the Oct 15, 2026 report: days to cover 7.8/25, change in short interest vs prior report 5.5/15, price change since settlement date 2/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of NVO daily volume is sold short?

41.5% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 67th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was NVO's latest FINRA short volume?

On Nov 2, 2026, cached FINRA short volume for Novo Nordisk A S (NVO) was 1,982,180 shares, 45.7% of 4,337,822 total volume.

How many NVO short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Novo Nordisk A S (NVO), from Oct 20, 2026 through Nov 2, 2026.

How did NVO short volume percent change from the prior cached session?

Cached FINRA short volume for Novo Nordisk A S (NVO) moved from 44.8% on Oct 30, 2026 to 45.7% on Nov 2, 2026, up 0.9 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.